Refine
Year of publication
Document Type
- Article (48)
- ZIB-Report (41)
- In Proceedings (22)
- Book chapter (6)
- Book (2)
- Doctoral Thesis (1)
- Habilitation (1)
- In Collection (1)
Is part of the Bibliography
- no (122)
Keywords
- Integer Programming (3)
- Mixed Integer Programming (3)
- Steiner tree (3)
- Branch-and-Bound (2)
- Optimization (2)
- Polyhedral Combinatorics (2)
- Steiner tree packing (2)
- UMTS (2)
- cutting planes (2)
- Branching Rules (1)
Institute
- Mathematical Optimization (57)
- ZIB Allgemein (36)
- Visual Data Analysis (6)
- Visual and Data-centric Computing (6)
- Mathematical Optimization Methods (4)
- Distributed Algorithms and Supercomputing (3)
- Mathematical Algorithmic Intelligence (3)
- Applied Algorithmic Intelligence Methods (2)
- Modeling and Simulation of Complex Processes (2)
- Numerical Mathematics (2)
Background: Metabolomics as one of the most rapidly growing technologies in the ?-omics?field denotes the comprehensive analysis of low molecular-weight compounds and their pathways. Cancer-specific alterations of the metabolome can be detected by high-throughput massspectrometric metabolite profiling and serve as a considerable source of new markers for the early differentiation of malignant diseases as well as their distinction from benign states. However, a comprehensive framework for the statistical evaluation of marker panels in a multi-class setting has not yet been established.
Methods: We collected serum samples of 40 pancreatic carcinoma patients, 40 controls, and 23 pancreatitis patients according to standard protocols and generated amino acid profiles by routine mass-spectrometry. In an intrinsic three-class bioinformatic approach we compared these profiles, evaluated their selectivity and computed multi-marker panels combined with the conventional tumor marker CA 19-9. Additionally, we tested for non-inferiority and superiority to determine the diagnostic surplus value of our multi-metabolite marker panels.
Results: Compared to CA 19-9 alone, the combined amino acid-based metabolite panel had a superior selectivity for the discrimination of healthy controls, pancreatitis, and pancreatic carcinoma patients [Volume under ROC surface (VUS) = 0.891 (95\% CI 0.794 - 0.968)].
Conclusions: We combined highly standardized samples, a three-class study design, a highthroughput mass-spectrometric technique, and a comprehensive bioinformatic framework to identify metabolite panels selective for all three groups in a single approach. Our results suggest that
metabolomic profiling necessitates appropriate evaluation strategies and ?despite all its current limitations? can deliver marker panels with high selectivity even in multi-class settings.